Fund Holdings — Octagon Capital Advisors LP

Total Portfolio Value
$798.77M
Total Bought
$147.43M
Total Sold
$155.60M
Net Transaction
-$8.17M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
COGENT BIOSCIENCES INC(COGT)2,874,1112,350,000-524,11141,27283,47210.45%+42,200
ALUMIS INC02,530,700+2,530,700024,7003.09%+24,700
PALISADE BIO INC(PALI)09,567,898+9,567,898022,4852.81%+22,485
KYMERA THERAPEUTICS INC(KYMR)360,000535,000+175,00020,37641,6285.21%+21,252
BIOAGE LABS INC(BIOA)01,598,000+1,598,000021,1422.65%+21,142
RAPT THERAPEUTICS INC0574,000+574,000019,4412.43%+19,441
TAYSHA GENE THERAPIES INC(TSHA)9,067,5008,859,911-207,58929,65148,7306.10%+19,079
LEXEO THERAPEUTICS INC(LXEO)01,725,000+1,725,000017,1292.14%+17,129
CIDARA THERAPEUTICS INC100,000100,00009,57622,0892.77%+12,513
TREVI THERAPEUTICS INC(TRVI)2,815,0002,815,000025,75735,2444.41%+9,487
EVOMMUNE INC(EVMN)0500,000+500,00008,5601.07%+8,560
PRECISION BIOSCIENCES INC(DTIL)01,917,995+1,917,99507,9791.00%+7,979
KALVISTA PHARMACEUTICALS INC1,273,3331,273,333015,50920,5642.57%+5,055
MIND MEDICINE MINDMED INC2,130,0002,230,000+100,00025,11329,8603.74%+4,747
DIANTHUS THERAPEUTICS INC(DNTH)2,416,6672,416,667095,09699,59112.47%+4,495
ARRIVENT BIOPHARMA INC(AVBP)1,971,0541,971,054036,36639,6584.96%+3,292
UNICYCIVE THERAPEUTICS INC(UNCY)1,000,0001,000,00004,3605,7700.72%+1,410
PEPGEN INC(PEPG)700,000700,00003,2344,5570.57%+1,323
OCULAR THERAPEUTIX INC(OCUL)2,624,0002,623,600-40030,67531,8513.99%+1,176
BRIDGEBIO ONCOLOGY THERAPEUT(BBOT)1,043,1101,043,110012,07913,0601.63%+981
DBV TECHNOLOGIES S A(DBVT)1,018,021574,200-443,82110,18011,0071.38%+827
PHARVARIS N V
COM
722,595671,465-51,13018,02918,6332.33%+604
NUVATION BIO INC(NUVB)104,1120-104,1123850—-385
CENTESSA PHARMACEUTICALS PLC830,000750,000-80,00020,12818,7582.35%-1,370
GOSSAMER BIO INC(GOSS)17,050,00013,915,371-3,134,62944,84243,1385.40%-1,704
STRUCTURE THERAPEUTICS INC115,0000-115,0003,2200—-3,220
NEUROGENE INC(NGNE)252,0000-252,0004,3670—-4,367
MAZE THERAPEUTICS INC(MAZE)177,6670-177,6674,6070—-4,607
CORBUS PHARMACEUTICALS HLDGS(CRBP)1,115,000955,000-160,00014,1057,7740.97%-6,331
NUVATION BIO INC(NUVB)2,633,3340-2,633,3349,7430—-9,743
ABIVAX SA(ABVX)1,325,000756,000-569,000112,493101,95012.76%-10,542
APELLIS PHARMACEUTICALS INC
COM
903,5000-903,50020,4460—-20,446
MERUS N V308,0000-308,00028,9980—-28,998
Page 1 of 1
Octagon Capital Advisors LP — 13F Holdings — Q4 2025 | TickerTrail